Go Deep
MiMedx Group, Inc.
MiMedx Group, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,362 | 117.2 | 3.17 | 0.08 | 446.65 |
| Oct 2026 | 21,352 | 117.5 | 3.17 | 0.08 | 446.25 |
| Oct 2026 | 21,372 | 117.0 | 3.16 | 0.08 | 444.42 |
| Oct 2026 | 21,620 | 110.8 | 2.99 | 0.08 | 419.59 |
| Oct 2026 | 21,669 | 109.5 | 2.96 | 0.08 | 415.30 |
| Oct 2026 | 21,818 | 105.8 | 2.86 | 0.08 | 401.07 |
| Oct 2026 | 22,303 | 93.5 | 2.53 | 0.08 | 353.74 |
| Oct 2026 | 22,115 | 98.2 | 2.65 | 0.08 | 370.96 |
MiMedx Group, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 64,362,000.0 | 58,991,000.0 | 118,095,000.0 | 113,725,000.0 |
| Net Profit | -14,840,000.0 | -10,860,000.0 | 15,191,000.0 | 16,748,000.0 |
| EPS | -0.1 | -0.1 | 0.1 | 0.1 |
MiMedx Group, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 418,630,000.0 | 348,879,000.0 | 321,477,000.0 | 267,841,000.0 | — |
| Net Profit | 48,578,000.0 | 42,419,000.0 | 58,228,000.0 | -30,197,000.0 | — |
| EPS | 0.3 | 0.3 | 0.4 | -0.3 | — |
MiMedx Group, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 342,653,000.0 | 263,915,000.0 | 239,047,000.0 | 171,430,000.0 | — |
| Total Liabilities | 86,105,000.0 | 70,808,000.0 | 96,330,000.0 | 189,418,000.0 | — |
| Total Equity | 256,548,000.0 | 193,107,000.0 | 142,717,000.0 | -17,988,000.0 | — |
Owes vs Owns
MiMedx Group, Inc. owed $0.23 for every $1 it owned in Jun 2026, down from $1.10 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.25× | 0.27× | 0.40× | 1.10× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
MiMedx Group, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 48.5%Receivables 22.1%Inventory 7.4%Fixed assets (tangible) 1.4%Intangible assets 9.8%Other assets 10.8%
How it's funded — Dec 2025
Long-term debt 4.8%Payables 4.2%Other liabilities 15.6%Shareholders' equity 74.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 166.1 | 104.4 | 82.0 | 66.0 |
| Receivables | 75.7 | 55.8 | 53.9 | 43.1 |
| Inventory | 25.3 | 23.8 | 21.0 | 13.2 |
| Fixed assets (tangible) | 4.7 | 5.9 | 9.1 | 11.3 |
| Intangible assets | 33.6 | 31.1 | 24.7 | 25.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 37.2 | 42.9 | 48.4 | 12.7 |
| Liabilities & equity | ||||
| Short-term debt | 1.5 | 1.0 | 1.0 | 0.0 |
| Long-term debt | 16.5 | 17.8 | 48.1 | 48.6 |
| Payables | 14.5 | 7.4 | 9.0 | 8.5 |
| Other liabilities | 53.6 | 44.6 | 38.2 | 132.4 |
| Shareholders' equity | 256.5 | 193.1 | 142.7 | -18.0 |
| Net tangible assets | 222.9 | 162.0 | 118.0 | -43.3 |
MiMedx Group, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 74,003,000.0 | 66,198,000.0 | 26,775,000.0 | -17,893,000.0 | — |
| Investing Activities | -6,886,000.0 | -9,583,000.0 | -2,155,000.0 | -2,660,000.0 | — |
| Financing Activities | -5,412,000.0 | -34,199,000.0 | -8,570,000.0 | -580,000.0 | — |